Solnica Bogdan, Sygitowicz Grażyna, Sitkiewicz Dariusz, Jóźwiak Jacek, Kasperczyk Sławomir, Broncel Marlena, Wolska Anna, Odrowąż-Sypniewska Grażyna, Banach Maciej
Polish Society for Laboratory Diagnostics.
Department of Clinical Biochemistry, Jagiellonian University Medical College, Krakow, Poland.
Arch Med Sci. 2024 Mar 18;20(2):357-374. doi: 10.5114/aoms/186191. eCollection 2024.
Lipid disorders are the most common (even 70%) and worst monitored cardiovascular risk factor (only 1/4 of patients in Poland and in CEE countries are on the low-density lipoprotein cholesterol (LDL-C) goal). To improve this, clear and simple diagnostic criteria should be introduced for all components of the lipid profile. These are the updated guidelines of the two main scientific societies in Poland in the area - the Polish Society of Laboratory Diagnostics (PSLD) and the Polish Lipid Association (PoLA), which, in comparison to those from 2020, introduce few important changes in recommendations (two main lipid targets, new recommendations on LDL-C measurements, calculations new goals for triglycerides, new recommendations on remnants and small dense LDL) that should help the practitioners to be early with the diagnosis of lipid disorders and in the effective monitoring (after therapy initiation), and in the consequence to avoid the first and recurrent cardiovascular events.
脂质紊乱是最常见的(甚至高达70%)且监测最差的心血管危险因素(在波兰和中东欧国家,只有四分之一的患者达到低密度脂蛋白胆固醇(LDL-C)目标)。为改善这种情况,应对血脂谱的所有成分引入清晰、简单的诊断标准。这些是波兰该领域两个主要科学协会——波兰实验室诊断学会(PSLD)和波兰脂质协会(PoLA)的最新指南,与2020年的指南相比,在建议方面有一些重要变化(两个主要脂质目标、关于LDL-C测量的新建议、计算甘油三酯的新目标、关于残余颗粒和小而密LDL的新建议),这应有助于从业者尽早诊断脂质紊乱并进行有效监测(治疗开始后),从而避免首次和复发性心血管事件。